Results 331 to 340 of about 7,353,326 (373)

Correction: Quality of life among women with symptomatic, screen‑detected, and interval breast cancer, and for women without breast cancer: a retrospective cross‑sectional study from Norway. [PDF]

Qual Life Res
Moshina N, Falk RS, Botteri E, Larsen M, Akslen LA, Cairns JA, Hofvind S.   +6 more
europepmc   +1 more source

Modeling of demoralization in breast cancer. [PDF]

Front Psychiatry
de Figueiredo JM, Kohn R, Chung JY, Gostoli S.   +3 more
europepmc   +1 more source

Reciprocal immune-epithelial interaction during breast cancer induction. [PDF]

J Immunother Cancer
Carleton N, Lotze MT.
europepmc   +1 more source

Correction: MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer

Biomarker Research
Xin-Yi Sui, Shuo-Wen Cao, Xiao-Qing Song, Xi-Yu Liu, Chao Chen, Qingya Yan, Zhi-Qing Wang, Wen-Juan Zhang, Lin-Xiaoxi Ma, Xi Jin, Ding Ma, Yi Xiao, Song-Yang Wu, Ying Xu, Zhi-Ming Shao, Lei Fan   +15 more
doaj   +1 more source

Alzheimer Disease in Breast Cancer Survivors.

JAMA Netw Open
Jeong SM, Jung W, Cho H, Choi HL, Jeon KH, Nam KW, Lee YG, Kim B, Han K, Shin DW.   +9 more
europepmc   +1 more source

Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program. [PDF]

Ann Surg Oncol
Keegan G, Ravenell J, Crown A, DiMaggio C, Joseph KA.   +4 more
europepmc   +1 more source

Liquid biopsy in breast cancer: Redefining precision medicine. [PDF]

J Liq Biopsy
Schiavone ML, Scarpitta R, Ravera F, Bleve S, Reduzzi C, Di Cocco F, Dameri M, Zoppoli G, Naccarato AG, Nuzzo PV, Cristofanilli M, Fanelli GN, Scatena C.   +12 more
europepmc   +1 more source

Talazoparib for prostate cancer and breast cancer. [PDF]

Aust Prescr
europepmc   +1 more source